Well‐differentiated thyroid cancers (WDTCs) are generally indolent cancers that are
associated with a low mortality. Although the incidence of these tumors is increasing, there …

Because of its relative rarity and favorable outcome, it has not been feasible to assess
medical interventions for thyroid cancer using randomized prospective trials. The approach …

Background Poorly differentiated thyroid cancer (PDTC) presents the endocrinologist and
surgeon with challenges of recognition and treatment given the lack of consensus on …

Differentiated thyroid cancer treatment Management of DTC requires a multidisciplinary
approach, 3 hence the need for a close cooperation between surgeons, endocrinologists …

Thyroid cancers are quite rare, accounting for only 1.5% of all cancers in adults and 3% of
all cancers in children. Differentiated thyroid cancer comprises 95% of all thyroid cancers. Of …

Differentiated thyroid carcinoma is a relatively indolent disease. Despite the usually
favorable prognosis, differentiated thyroid cancer is fatal in some patients. In the past …

Differentiated thyroid carcinoma is a rare disease. Appropriate diagnosis, treatment and
follow-up are complex but greatly influence treatment outcomes and patient quality of life …

With improved understanding of the biology of differentiated thyroid carcinoma its
management is evolving. The approach to surgery for the primary tumour and elective nodal …

Background The study evaluates clinical presentation and outcome of differentiated thyroid
cancer (DTC) on a large series of patients homogeneously managed. Patients and methods …

The majority of thyroid cancers are slow growing and have an excellent prognosis after
surgical and medical therapy. However, a subset of thyroid cancers do not follow an indolent …